Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 17, 2026
Why Is Oddity Tech Ltd. (ODD) Stock Down -9.84% Today?

Why Is Oddity Tech Ltd. (ODD) Stock Down -9.84% Today?

Key Takeaways

  • Shares of ODD were down 9.84% intraday Monday at $11.82, a decline of $1.29 from the prior close of $13.11.
  • The selling extended a prolonged repricing tied to elevated customer-acquisition costs following a February “dislocation” with the company’s largest advertising partner.
  • First-quarter results underscored the pressure: revenue fell 26% year over year and the company swung to a net loss.
  • Wall Street sentiment remains cautious after downgrades and price-target cuts, while securities class action filings add legal overhang.
  • Traders are now watching the company’s second-quarter earnings release, scheduled for September 9, 2026.

Opening Summary

Oddity Tech Ltd. (ODD), the digital-first beauty and wellness company behind the IL MAKIAGE and SpoiledChild brands, saw its shares fall sharply during Monday’s session. The stock traded at $11.82, down $1.29, or 9.84%, from Friday’s closing price of $13.11, extending a months-long decline that has kept investor sentiment firmly negative. The immediate driver cited by markets was continued concern over the company’s customer-acquisition model, which has been under pressure since management disclosed a disruption with its largest advertising partner earlier this year.

Customer-Acquisition Dislocation Remains the Central Concern

The core issue weighing on ODD dates back to February, when the company disclosed that an algorithm change at its largest advertising partner had diverted advertisements to lower-quality auctions at abnormally high costs. The resulting jump in customer-acquisition costs forced management to warn that first-quarter revenue would decline roughly 30% year over year, triggering a historic single-day selloff.

That pressure was confirmed in the company’s first-quarter results. Revenue fell 26% year over year to $197.9 million, and the company swung to a net loss of $21.4 million. Management also guided for a 25% to 30% year-over-year revenue decline in the second quarter, signaling that the disruption has not yet fully normalized. While the company has pointed to a sequential improvement in IL MAKIAGE customer-acquisition costs in May, investors remain unconvinced that a durable recovery is underway.

Cautious Wall Street Stance and Legal Overhang

The decline has been reinforced by a cautious sell-side view. Several analysts have downgraded the stock or reduced price targets, reflecting low visibility on the timing of a recovery in customer-acquisition efficiency and repeat-purchase behavior. The broader consensus on ODD has shifted to a guarded posture, with firms citing execution risk even as they acknowledge early signs of stabilization.

Separately, securities class action filings tied to the company’s disclosures about its advertising platform have added a layer of uncertainty. The legal overhang, combined with the operational reset, has made it difficult for the shares to sustain any meaningful bounce.

Market Context and Trading Activity

The move in ODD reflects company-specific pressures rather than a broad shift in the personal-care sector. The stock has been highly volatile, consistent with its elevated beta, and Monday’s decline pushed it deeper below its 50-day and 200-day moving averages, reinforcing a bearish technical setup. Over the past year, the shares have lost roughly three-quarters of their value, underscoring how dramatically the market has repriced the company’s growth outlook since the advertising dislocation emerged.

What Comes Next for ODD

The next major catalyst for ODD is its second-quarter earnings report, scheduled for September 9, 2026. Investors will focus on whether customer-acquisition costs continue to normalize, whether the company can stabilize first-order trends, and whether newer initiatives such as the METHODIQ medical telehealth brand can gain traction. Management has said it expects positive adjusted EBITDA for the full year, but execution risk remains elevated. Legal proceedings, advertising-platform dependence, and the broader consumer environment all remain key uncertainties heading into the report.

Trending AI Robots

Tickeron’s Trending AI Robots page features a curated selection of AI trading bots that are currently showing strength under live market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, and only the strongest performers are highlighted in this section. The bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a way to explore systematic approaches across different market environments. Visit the page to see which strategies are leading right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: ODD

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for ODD turns negative, indicating new downward trend

ODD saw its Momentum Indicator move below the 0 level on July 29, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 57 similar instances where the indicator turned negative. In of the 57 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for ODD turned negative on July 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 27 similar instances when the indicator turned negative. In of the 27 cases the stock turned lower in the days that followed. This puts the odds of success at .

ODD moved below its 50-day moving average on August 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ODD crossed bearishly below the 50-day moving average on August 12, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ODD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ODD entered a downward trend on August 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ODD advanced for three days, in of 171 cases, the price rose further within the following month. The odds of a continued upward trend are .

ODD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.023) is normal, around the industry mean (24.451). P/E Ratio (16.595) is within average values for comparable stocks, (54.593). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.018). ODD has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.034). P/S Ratio (1.075) is also within normal values, averaging (2.440).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ODD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ODD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL).

Industry description

Household/Personal Care companies sell products for home cleaning and/or personal hygiene and grooming purposes. Products of this industry include detergents, shampoos, soaps, cosmetics, fabric conditioners and infant care fragrances. Procter & Gamble, Unilever, Estee Lauder and Colgate-Palmolive are some of the biggest names in the business. A lot of the products become a necessary part of people’s daily routine, and therefore the industry is relatively less vulnerable to macroeconomic downturns. At the same time, product quality, consumer safety, and ease of use are extremely critical factors for a company to survive competition and earn recognition in this industry.

Market Cap

The average market capitalization across the Household/Personal Care Industry is 22.76B. The market cap for tickers in the group ranges from 81.32K to 336B. PG holds the highest valuation in this group at 336B. The lowest valued company is QNTA at 81.32K.

High and low price notable news

The average weekly price growth across all stocks in the Household/Personal Care Industry was -4%. For the same Industry, the average monthly price growth was -0%, and the average quarterly price growth was -6%. ACU experienced the highest price growth at 8%, while NUS experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Household/Personal Care Industry was -26%. For the same stocks of the Industry, the average monthly volume growth was -31% and the average quarterly volume growth was -56%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 51
Price Growth Rating: 54
SMR Rating: 71
Profit Risk Rating: 91
Seasonality Score: -38 (-100 ... +100)
View a ticker or compare two or three
ODD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry HouseholdPersonalCare

Profile
Details
Industry
N/A
Address
8 Haharash Street
Phone
+972 52 501 4724
Employees
658
Web
https://www.oddity.com
Interact to see
Advertisement
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Cincinnati Financial (CINF) reports Q4 2025 earnings on February 9, 2026, after market close, with consensus EPS of $2.86–$2.89 and revenue around $2.91 billion. Allstate (ALL) recently reported Q4 2025 EPS of $14.31, well above the $8.72 estimate, with revenue of $17.3 billion on February 4, 2026.
Gilead Sciences (GILD): Q4 2025 earnings due February 10, consensus EPS $1.83, revenue $7.68B. Growth driven by HIV franchise; oncology investments like Trodelvy may offer upside. Amgen (AMGN): Reported Q4 2025 EPS $5.29 vs $4.73 expected, revenue $9.9B (+9% YoY). Strong 2026 guidance: $37–38.4B revenue, $21.60–23.00 non-GAAP EPS.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
CME Group delivered record 2025 revenue of $6.52 billion, up 6% year-over-year. Q4 adjusted EPS of $2.77 exceeded expectations.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Q4 2025 revenue reached $12.5 billion, exceeding expectations, with growth portfolio sales up 16% year-over-year. Full-year 2025 revenue totaled $48.2 billion, supported by Eliquis, Opdivo, and newer products including Breyanzi and Camzyos.
KKR reported Q4 2025 adjusted EPS of $1.12, slightly below the $1.14 consensus estimate. The firm raised a record $129 billion in 2025, surpassing 80% of its $300 billion fundraising goal for 2024–2026.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.